ArticleNature communications2019
Interval breast cancer is associated with other types of tumors.
Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 38 citations in OpenAlex.
- Blood DNA methylation and breast cancer risk: a prospective nested case-control study.EBioMedicine · 2026Article
- Under-recognized risk factors and low perceived breast cancer risk among rural women in South-central China: A multisite cross-sectional study.Asia-Pacific journal of oncology nursing · 2025Article
- Review
- Incidence and Risk Factors of Interval and Screen-Detected Breast Cancer.JAMA oncology · 2025Article
- Development and evaluation of 3D-printed tumor palpation models for surgical training and patient education.3D printing in medicine · 2024Article
- Genetic landscape of interval and screen detected breast cancer.NPJ precision oncology · 2024Article
- Long-term trends in incidence, characteristics and prognosis of screen-detected and interval cancers in women participating in the Dutch breast cancer screening programme.British journal of cancer · 2024Article
- Comprehensive Inherited Risk Estimation for Risk-Based Breast Cancer Screening in Women.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024Article
- The impact of circulating protein levels identified by affinity proteomics on short-term, overall breast cancer risk.British journal of cancer · 2024Article
- Development and testing of a polygenic risk score for breast cancer aggressiveness.NPJ precision oncology · 2023Article
- Article
- Impact of Detection Mode in a Large Cohort of Women Taking Part in a Breast Screening Program.European journal of breast health · 2022Article
- Missed Breast Cancers on MRI in High-Risk Patients: A Retrospective Case-Control Study.Tomography (Ann Arbor, Mich.) · 2022Article
- Diet-Driven Inflammation and Insulinemia and Risk of Interval Breast Cancer.Nutrition and cancer · 2022Article
- Mammographic features are associated with cardiometabolic disease risk and mortality.European heart journal · 2021Article
- Increased risk of breast cancer-specific mortality among cancer survivors who developed breast cancer as a second malignancy.BMC cancer · 2021Article
- Article
- Incidence, Characteristics, and Outcomes of Interval Breast Cancers Compared With Screening-Detected Breast Cancers.JAMA network open · 2020Observational
- Comparison of Mortality Among Participants of Women's Health Initiative Trials With Screening-Detected Breast Cancers vs Interval Breast Cancers.JAMA network open · 2020Article
- Interval breast cancers - insights into a complex phenotype.Nature reviews. Clinical oncology · 2020Article
Corrections and comments
- Commented on by
Authors and funding
6 authors at 1 institution in 1 country.
Funding
Abstract
Breast cancer (BC) patients diagnosed between two screenings (interval cancers) are more likely than screen-detected patients to carry rare deleterious mutations in cancer genes potentially leading to increased risk for other non-breast cancer (non-BC) tumors. In this study, we include 14,846 women diagnosed with BC of which 1,772 are interval and 13,074 screen-detected. Compared to women with screen-detected cancers, interval breast cancer patients are more likely to have a non-BC tumor before (Odds ratio (OR): 1.43 [1.19-1.70], P = 9.4 x 10
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.